Research subcommittee survey

The research subcommittee would like to invite members to support this collaborative research project on the national variation in the treatment for nausea and vomiting for adult patients receiving systematic anti-cancer therapy. It aims to explore the possibility of standardising antiemetic protocols at a national level with the goal of reducing hospitalisations and improving patient care.

We invite each hospital to complete the survey https://forms.office.com/e/Eh4rGiq31r and each trust needs to respond only once. It should take around 10 minutes of your time.

The results will be shared across relevant networks, and we hope further research will confirm the findings from this survey and identify areas in which additional evidence is needed

Latest News

By BOPA on 8th September 2026

Register now: Immunotherapy: Beyond Checkpoint Inhibitors

Immunotherapy: Beyond Checkpoint Inhibitors WHEN: Tuesday 17th November 2026 WHERE:  Wellcome Collection, 183 Euston Road, London, NW1 BE COST: A non-refundable payment of £25.00. We are pleased to announce registration is now available for…

Read article
By BOPA Executive Committee on 7th September 2026

Royal College of Pharmacy launch its new Enhanced Curriculum and Credentialing Pathway

We are delighted to see the Royal College of Pharmacy launch its new Enhanced Curriculum and Credentialing Pathway today. This curriculum is the product of a truly collaborative effort across…

Read article
By NHS Infusions and Special Medicines Programme on 4th September 2026

Expressions of interest for Expert Panel Sub Group to support the approval and implementation of Standardised Product Specifications

Expressions of interest for Expert Panel Sub Group to support the approval and implementation of Standardised Product Specifications The Infusions and Special Medicines Programme is inviting expressions of interest for…

Read article
By BOPA on 31st August 2026

🌟 BOPA Advanced Pharmacist Study Day – Elevate Your Practice, Shape Your Career

Are you an oncology or haematology pharmacist with around five or more years of experience — whether Band 7 or Band 8 — and ready to take the next step…

Read article